sonepiprazole has been researched along with ngd 94-1 in 3 studies
| Studies (sonepiprazole) | Trials (sonepiprazole) | Recent Studies (post-2010) (sonepiprazole) | Studies (ngd 94-1) | Trials (ngd 94-1) | Recent Studies (post-2010) (ngd 94-1) |
|---|---|---|---|---|---|
| 20 | 1 | 5 | 15 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bristow, LJ; Hutson, PH; Rowley, M | 1 |
| Gmeiner, P; Kortagere, S; Schetz, JA; Weinstein, H | 1 |
| Hopkins, CR; Lindsley, CW | 1 |
2 review(s) available for sonepiprazole and ngd 94-1
| Article | Year |
|---|---|
Current and novel approaches to the drug treatment of schizophrenia.
Topics: Animals; Antipsychotic Agents; Cholinergic Agonists; Disease Models, Animal; Dopamine Antagonists; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Mice; Mice, Transgenic; Nitric Oxide Synthase; Receptor, Serotonin, 5-HT2A; Receptors, AMPA; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotensin; Receptors, Serotonin; Schizophrenia; Serotonin Antagonists | 2001 |
Return of D
Topics: Animals; Drug Discovery; Humans; Ligands; Molecular Targeted Therapy; Neoplasms; Parkinson Disease; Receptors, Dopamine D4; Small Molecule Libraries; Substance-Related Disorders | 2017 |
1 other study(ies) available for sonepiprazole and ngd 94-1
| Article | Year |
|---|---|
Certain 1,4-disubstituted aromatic piperidines and piperazines with extreme selectivity for the dopamine D4 receptor interact with a common receptor microdomain.
Topics: Animals; Binding Sites; Chlorocebus aethiops; COS Cells; Mutagenesis, Site-Directed; Piperazines; Piperidines; Radioligand Assay; Rats; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins; Structure-Activity Relationship | 2004 |